Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Blood Banking and Transfusion Medicine

Buch | Hardcover
640 Seiten
2002
Churchill Livingstone (Verlag)
978-0-443-06542-2 (ISBN)
CHF 246,15 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
Offers readers a practical approach to blood banking and transfusion medicine. This reference work examines advances in molecular genetics and the scientific mechanisms underlying the field. It explains their applications in clinical practice. It features a consistent chapter organization and nearly 500 crisp illustrations.
This new reference offer readers today's most practical approach to blood banking and transfusion medicine. It examines new advances in molecular genetics and the scientific mechanisms underlying the field ...and explains their applications in clinical practice. A consistent chapter organization and nearly 500 crisp illustrations make this resource exceptionally easy to use.

Christopher D. Hillyer, MD, is President and CEO of New York Blood Center and Professor, Department of Medicine, Weill Cornell Medical College, New York, NY. Previously, he was the tenured, endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine and served as director of the Emory Center for Transfusion and Cellular Therapies with responsibility for all aspects of clinical and academic transfusion medicine at Emory's seven principle hospitals. Dr. Hillyer is an editor of twelve textbooks in transfusion medicine, author of over 160 articles pertaining to transfusion, human immunodeficiency virus, and herpes viruses, most notably cytomegalovirus. Nationally recognized as an expert in hematology and blood transfusion, Dr. Hillyer is also a past-president, board of directors of AABB and a former trustee of the National Blood Foundation. Dr. Hillyer has been awarded many million dollars in research funding from the National Institutes of Health, the Centers for Disease Control and Prevention and other agencies. He was an associate editor of Transfusion and serves on several other editorial boards. Dr. Hillyer was formally recognized for his work in Africa as part of the AABB/Emory cooperative agreement from the President's Emergency Plan For AIDS Relief (PEPFAR), and is a recipient of two Tiffany Awards from the American Red Cross where he also served as a medical director and a member of their national Medical Advisory Board. He also received the 2014 Emily Cooley Award from AABB for his significant commitment and contributions to the field of transfusion medicine through extensive teaching, mentoring and professional leadership, and the countless clinical, scientific and innovative resource materials he has created to educate others". He is a co-founder of Transfusion & Transplantation Technologies, Inc (3Ti) and holds over 20 patents or patents pending. Dr. Hillyer is board certified in transfusion medicine, hematology, medical oncology and internal medicine. He received his BS from Trinity College, and his MD from the University of Rochester School of Medicine, with postgraduate training and fellowships in hematology-oncology, transfusion medicine and bone marrow transplantation at Tufts-New England Medical Center.

  • Evolution to the 21st Century
  • ABO and Related Antigens
  • Rh
  • Clinically Significant Antigens
  • Other Antigens
  • Platelet Antigens
  • HLA and Granulycte Antigens
  • Information to Blood Donors and Donation
  • Informed Consent
  • Lookback Investigations
  • Product Recall/Withdrawal
  • Quality Improvement/Control
  • Component Preparation and Storage
  • Infectious Disease Testing
  • Packed RBCs and Related Products
  • Fresh Frozen Plasma and Related Products
  • Cryoprecipitate and Related Products
  • Albumin, lvlg and Derivatives
  • Platelets and Related Products
  • Granulocytes
  • Coagulation Factor Preparations
  • Leukocyte Reduced Products
  • Virus-Safe Products
  • Irradiated Products
  • Washed/Volume Reduced Products
  • Blood Substitutes
  • Alternative to Allogeneic Transfusion
  • Red Blood Cell Transfusion and the Transfusion Trigger
  • Transfusion in the Surgical Setting
  • Transfusion of the Patient with Congenitally Coagulation Defects
  • Transfusion of the Patient with Acquired Coagulation Defect
  • Obstetric and Intrauterine Transfusion
  • Transfusion of the Neonate and Pediatric Patient
  • Transfusion of the Hemoglobinopathies
  • Transfusion to Bone Marrow Transplant, Organ Transplant Recipient, and HIV+ Patients
  • Transfusion of the Platelet Refactory Patient
  • Transfusion of the Hemolytic Anemias
  • Bone Marrow Transplantation
  • Peripheral Blood Stem Cell Transplantation
  • Umbilical Cord Blood Stem Cell Transplantation
  • Mononuclear Cell Preparations
  • Complication of Cellular Therapy
  • Acute Transfusion Reactions
  • Delayed
  • Febrile Transfusion Reactions
  • Allergic Transfusion Reactions
  • Other Non-Infectious Complication
  • Immunomodulation
  • 48a. Microchimerism and GVHD
  • Hepatitis A, B, and other Non-A, Non-B, Non-C Viruses
  • Hepatitis C
  • HIV
  • HTLV and Other Retroviruses
  • Human Herpes Virus Infections
  • Bacterial Infections
  • Additional Infectious Complications
  • Practical, Technical and Adverse Reaction
  • Therapeutic Plasma Exchange
  • Cytapheresi

  • Zusatzinfo Over 495 ills
    Verlagsort London
    Sprache englisch
    Maße 216 x 276 mm
    Gewicht 2060 g
    Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
    Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
    ISBN-10 0-443-06542-X / 044306542X
    ISBN-13 978-0-443-06542-2 / 9780443065422
    Zustand Neuware
    Haben Sie eine Frage zum Produkt?
    Mehr entdecken
    aus dem Bereich
    Hämatologie und Internistische Onkologie

    von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

    Buch | Softcover (2023)
    ecomed-Storck GmbH (Verlag)
    CHF 179,95